Biomedical Diagnostics at Point-of-Care 2019-2029: Technologies, Applications, Forecasts

This report focuses on the advanced techniques of biosensors biomedical diagnostics at point-of-care. The techniques include microfluidic, lab-on-a-chip, lateral flow assays, electrochemical test strip, molecular diagnostics and DNA sequencing. These techniques and devices are used to diagnose genetic disease, infectious disease, cardiometabolic, pregnancy and fertility, diabetic and cancer. We predict the market for biomedical diagnostics will reach $43 billion by 2029, mainly driven by the fast growth of molecular diagnostics in the coming years

Login or Register You are not logged in. For existing users, please login to learn more about this premium content. For new users, please register with idtechex.com or use the links below for more details about premium content from IDTechEx.

Subscription Benefits


A subscription from IDTechEx allows you to access our full body of research content on emerging technologies, including market, technology and company data, alongside direct engagement with our expert analysts.
Subscription content includes:
  • Market research reports
  • Forecasts
  • Premium articles
  • Company profiles
  • Industry digests
  • Webinars
  • Innovation maps
  • Event summaries and write-ups

Report Statistics

Slides
270
Forecasts to
2029